Vasoinhibins:: endogenous regulators of angiogenesis and vascular function

被引:88
作者
Clapp, Carmen [1 ]
Aranda, Jorge [1 ]
Gonzalez, Carmen [1 ]
Jeziorski, Michael C. [1 ]
de la Escalera, Gonzalo Martinez [1 ]
机构
[1] Univ Nacl Autonoma Mexico, Inst Neurobiol, Queretaro 76230, Mexico
关键词
D O I
10.1016/j.tem.2006.08.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vasoinhibins are a family of peptides derived from prolactin, growth hormone and placental lactogen that act on endothelial cells to suppress vasodilation and angiogenesis and to promote apoptosis-mediated vascular regression. Some of the pathways by which vasoinhibins act have now been defined, and recent developments indicate that endogenous vasoinhibins exert tonic and essential actions on blood vessel growth, dilation and regression in vivo. By studying the pathways that can generate vasoinhibins, and the nature of their receptors and key biological mediators, it should be possible to clarify the role of vasoinhibins in controlling vascular function in health and disease.
引用
收藏
页码:301 / 307
页数:7
相关论文
共 57 条
  • [1] Prolactins are natural inhibitors of angiogenesis in the retina
    Aranda, J
    Rivera, JC
    Jeziorski, MC
    Riesgo-Escovar, J
    Nava, G
    López-Barrera, F
    Quiróz-Mercado, H
    Berger, P
    de la Escalera, GM
    Clapp, C
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46 (08) : 2947 - 2953
  • [2] Bentzien F, 2001, CANCER RES, V61, P7356
  • [3] Prolactin (PRL) and its receptor: Actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice
    Bole-Feysot, C
    Goffin, V
    Edery, M
    Binart, N
    Kelly, PA
    [J]. ENDOCRINE REVIEWS, 1998, 19 (03) : 225 - 268
  • [4] Cao Yihai, 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P667, DOI 10.2174/1568011023353705
  • [5] THE 16-KILODALTON N-TERMINAL FRAGMENT OF HUMAN PROLACTIN IS A POTENT INHIBITOR OF ANGIOGENESIS
    CLAPP, C
    MARTIAL, JA
    GUZMAN, RC
    RENTIERDELRUE, F
    WEINER, RI
    [J]. ENDOCRINOLOGY, 1993, 133 (03) : 1292 - 1299
  • [6] A SPECIFIC, HIGH-AFFINITY, SATURABLE BINDING-SITE FOR THE 16-KILODALTON FRAGMENT OF PROLACTIN ON CAPILLARY ENDOTHELIAL-CELLS
    CLAPP, C
    WEINER, RI
    [J]. ENDOCRINOLOGY, 1992, 130 (03) : 1380 - 1386
  • [7] THE PROLACTIN GENE IS EXPRESSED IN THE HYPOTHALAMIC-NEUROHYPOPHYSEAL SYSTEM AND THE PROTEIN IS PROCESSED INTO A 14-KDA FRAGMENT WITH ACTIVITY LIKE 16-KDA PROLACTIN
    CLAPP, C
    TORNER, L
    GUTIERREZOSPINA, G
    ALCANTARA, E
    LOPEZGOMEZ, FJ
    NAGANO, M
    KELLY, PA
    MEJIA, S
    MORALES, MA
    DELAESCALERA, G
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (22) : 10384 - 10388
  • [8] Proteolytic cleavage confers nitric oxide synthase inducing activity upon prolactin
    Corbacho, AM
    Nava, G
    Eiserich, JP
    Noris, G
    Macotela, Y
    Struman, I
    de la Escalera, GM
    Freeman, BA
    Clapp, C
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (18) : 13183 - 13186
  • [9] Roles of prolactin and related members of the prolactin/growth hormone/placental lactogen family in angiogenesis
    Corbacho, AM
    de las Escalera, GM
    Clapp, C
    [J]. JOURNAL OF ENDOCRINOLOGY, 2002, 173 (02) : 219 - 238
  • [10] Human umbilical vein endothelial cells express multiple prolactin isoforms
    Corbacho, AM
    Macotela, Y
    Nava, G
    Torner, L
    Dueñas, Z
    Noris, G
    Morales, MA
    de la Escalera, GM
    Clapp, C
    [J]. JOURNAL OF ENDOCRINOLOGY, 2000, 166 (01) : 53 - 62